C3is Inc. Announces Pricing of $6.0 Million Underwritten Public Offering
Rhea-AI Summary
C3is (Nasdaq: CISS) priced an underwritten public offering of 11,535,000 units at $0.52 per unit, for expected gross proceeds of approximately $6.0 million before fees. Each unit includes one common share (or pre-funded warrant) and one Class F warrant to purchase one common share.
According to C3is, the warrants are immediately exercisable, expire one year from issuance and initially have a $0.52 exercise price. This price will be adjusted on the second and fifth trading days after closing to 70% and 50%, respectively, of the initial exercise price, with the underlying share count proportionally increased. Warrants may also be exercised on a zero cash basis, exchanging each warrant for twice the number of shares issuable on a cash exercise. The company granted underwriters a 45‑day option to buy up to 908,765 additional shares and/or warrants. Closing is expected on or about July 28, 2026, subject to customary conditions.
Positive
- $6.0 million expected gross proceeds from offering before fees
- Underwriters’ 45-day option could increase total capital raised
- Warrants immediately exercisable, potentially providing additional capital inflows
Negative
- Issuance of 11,535,000 units implies significant potential shareholder dilution
- Class F warrants include price reset features that may increase dilution
- Underwriters’ option for up to 908,765 extra shares and/or warrants adds further dilution risk
Market reaction after $6.0 million public offering: CISS -80.31% in the Jul 27 session
In the Jul 27 session, CISS declined 80.31%, reflecting a significant negative market reaction. Argus tracked a peak move of +11.2% during that session. Argus tracked a trough of -79.7% from its starting point during tracking. Our momentum scanner triggered 144 alerts that day, indicating very high trading interest and price volatility. Trading volume was exceptionally heavy at 183.8x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Offering Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 12 | Offering closing | Negative | -24.2% | Public offering closed, raising gross proceeds through units containing shares and warrants. |
| Dec 11 | Offering pricing | Negative | -80.7% | Public offering priced with units containing common shares and multiple warrant classes. |
| Oct 09 | Direct offering closing | Negative | -5.0% | Registered direct offering closed, selling common shares for aggregate gross proceeds. |
| Oct 08 | Direct offering pricing | Negative | -36.6% | Registered direct offering priced at $2.50 per share for gross proceeds. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
All four tag-specific offering events had negative 24-hour reactions, with an average move of -36.65%.
Key Terms
underwritten public offering financial
pre-funded warrant financial
zero cash exercise option financial
form f-1 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
ATHENS, Greece, July 27, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing seaborne transportation services, today announced the pricing of its underwritten public offering of 11,535,000 units at a public offering price of
Each warrant will expire one (1) year from the date of issuance, will be immediately exercisable upon issuance at an initial exercise price of
Gross proceeds to the Company, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately
Maxim Group LLC is acting as sole book-running manager in connection with the offering.
The Company has granted the underwriters a 45-day option to purchase up to an additional 908,765 common shares and/or additional warrants to purchase up to 908,765 common shares, at its respective public offering price less underwriting discounts and commissions.
A registration statement on Form F-1 (File No. 333-297627), as amended, was filed with the U.S. Securities and Exchange Commission (“SEC”) and became effective in accordance with Section 8(a) of the Securities and Exchange Act of 1933, as amended, on July 27, 2026. A final prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at http://www.sec.gov. The offering is being made only by means of a prospectus forming part of the effective registration statement. Electronic copies of the prospectus relating to this offering, when available, may also be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, New York 10022, Attention: Syndicate Department, by telephone at (212) 895-3745 or by email at syndicate@maximgrp.com.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About C3is Inc.
C3is Inc. is a ship-owning company providing seaborne transportation services to dry bulk and tanker charterers, including major national and private industrial users, commodity producers and traders.
On a pro forma basis following the delivery of one additional MR product tanker it has contracted to acquire, the Company's fleet will consist of six vessels: three Handysize dry bulk carriers, one Aframax tanker, and two MR product tankers, with a total carrying capacity of approximately 311,431 dwt.
C3is Inc.’s common shares are listed on the Nasdaq Capital Market and trade under the symbol “CISS”.
Forward Looking Statements
Matters discussed in this release may constitute forward-looking statements within the meaning of the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the completion of the offering and other statements that are forward-looking. Forward-looking statements reflect our current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. The forward-looking statements in this release are based upon various assumptions. Although C3is Inc. believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, C3is Inc. cannot assure you that it will achieve or accomplish these expectations, beliefs or projections. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include uncertainties related to the timing and completion of the offering, including satisfaction of customary closing conditions related to the offering, as well as those risks discussed under “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2025 and our filings with the U.S. Securities and Exchange Commission (the “SEC”). Except to the extent required by applicable law, C3is Inc. disclaims any intention or obligation to update publicly or revise any forward‐looking statements, whether as a result of new information, future events or otherwise.
Company Contact
Nina Pyndiah
Chief Financial Officer
C3is Inc.
00-30-210-6250-001
E-mail: info@c3is.pro
